BOLT
#4840
Bolt Biotherapeutics, Inc. - Common Stock
3.8 9 USD
-0.03%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.75%
Monthly Change
+0.26%
6 month change
-13.94%
Year Change
-24.76%
Previous Close
4.0 0
Open
4.0 0
Low
3.7 4
High
4.0 0
Volume
28
Financials
- Market Capitalization 7.49 M
- Employee 23
- Founded 2015
- CEO N/A
- Website www.boltbio.com
- Headquarter Delaware, United States
- FIGI BBG00N8MY5V9
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.31
Price to sales ratio
1.33
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4836 |  ERNA Ernexa Therapeutics Inc. - Common Stock | 4.57 USD | -2.14% | -4.99% | +32.46% | +1207.58% | 7.46 M USD | ||
| 4837 |  CELZ Creative Medical Technology Holdings, Inc. - Common Stock | 1.14 USD | 0.00% | -11.63% | +58.33% | -63.58% | 7.52 M USD | ||
| 4842 |  NCNA NuCana plc - American Depositary Shares | 1.76 USD | +19.73% | +17.33% | +43.09% | -18.14% | 7.33 M USD | ||
| 4849 |  CURX Curanex Pharmaceuticals Inc - Common Stock | 4.56 USD | -2.56% | -2.98% | +2180.00% | -15.87% | 7.15 M USD |
Frequently asked questions about Bolt Biotherapeutics, Inc. Common Stock
What is the Bolt Biotherapeutics, Inc. Common Stock stock price today?
The current price of Bolt Biotherapeutics, Inc. Common Stock (BOLT) is 3.89. Over the past 24 hours, the stock has changed by -2.75%. Follow the BOLT chart for real-time price dynamics.
What is the stock ticker of Bolt Biotherapeutics, Inc. Common Stock?
Bolt Biotherapeutics, Inc. Common Stock trades under the ticker BOLT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Bolt Biotherapeutics, Inc. Common Stock stock going up?
BOLT has changed by +6.58% over the last week, +0.26% over the last month, and -24.76% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Bolt Biotherapeutics, Inc. Common Stock?
Bolt Biotherapeutics, Inc. Common Stock currently has a market capitalization of 7.49 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Bolt Biotherapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Bolt Biotherapeutics, Inc. Common Stock reported earnings of -4.57 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Bolt Biotherapeutics, Inc. Common Stock revenue for the last quarter?
Bolt Biotherapeutics, Inc. Common Stock reported quarterly revenue of 5 000. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Bolt Biotherapeutics, Inc. Common Stock net income for the last quarter?
Bolt Biotherapeutics, Inc. Common Stock reported net income of -7.72 M for the last quarter. The previous quarter showed -7.24 M, which means net income changed by -6.57%.
How many employees does Bolt Biotherapeutics, Inc. Common Stock have?
As of the latest available data, Bolt Biotherapeutics, Inc. Common Stock has 23 employees. Workforce size can provide additional context about the company's scale and operations.
What is Bolt Biotherapeutics, Inc. Common Stock EBITDA?
Bolt Biotherapeutics, Inc. Common Stock EBITDA is -8.2 M, and its EBITDA margin is -164.06 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Bolt Biotherapeutics, Inc. Common Stock stock?
You can buy Bolt Biotherapeutics, Inc. Common Stock (BOLT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Bolt Biotherapeutics, Inc. Common Stock stock?
Investing in Bolt Biotherapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BOLT chart and related analysis on metatrader.com as part of your research.